Drug Shortage Report for ZITHROMAX - PWS ORL 100MG/5ML

Last updated on 2018-11-02 History
Report ID 33938
Drug Identification Number 02223716
Brand name ZITHROMAX - PWS ORL 100MG/5ML
Common or Proper name Zithromax
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) AZITHROMYCIN
Strength(s) 100MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size 300mg/15mL
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-04-20
Estimated end date
Actual end date 2018-11-01
Shortage status Resolved
Updated date 2018-11-02
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v28 2018-11-02 English Compare
v27 2018-11-01 French Compare
v26 2018-11-01 English Compare
v25 2018-11-01 French Compare
v24 2018-11-01 English Compare
v23 2018-09-25 French Compare
v22 2018-09-25 English Compare
v21 2018-08-15 French Compare
v20 2018-08-15 English Compare
v19 2018-05-17 French Compare
v18 2018-05-17 English Compare
v17 2018-04-24 French Compare
v16 2018-04-24 English Compare
v15 2018-04-21 English Compare
v14 2018-04-20 French Compare
v13 2018-04-20 English Compare
v12 2018-04-17 English Compare
v11 2018-02-21 French Compare
v10 2018-02-21 English Compare
v9 2018-02-13 French Compare

Showing 1 to 20 of 28